Omeprazen (Omeprazole)

Omeprazole, the active ingredient in Omeprazen, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces stomach acid production and is used to manage gastro‑reflux and other acid‑related disorders in adults and children.

GNH USA supplies Omeprazen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease (PUD): supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome (ZES): controls excessive gastric acid secretion associated with the syndrome. - Helicobacter pylori eradication regimens: used as part of a combination therapy to improve eradication rates. - NSAID‑associated gastric protection: helps prevent the development of gastric ulcers in at‑risk patients.

Omeprazole is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects: - Headache  - Diarrhea  - Nausea  - Abdominal pain  - Flatulence  - Constipation 

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis  - Acute interstitial nephritis  - Severe cutaneous adverse reactions (e.g., Stevens‑Johnson syndrome). - Hypersensitivity  - Vitamin B12 deficiency with long‑term use. - Bone fracture  - Low‑titer p ​    

Omeprazole should be used with caution: -   g   t  t  ewline  ewline  ewline  ewline  ewline \n

t  ewline ullet   ewline ullet ullet  ewline ullet ullet  ewline 

\